Related references
Note: Only part of the references are listed.Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi et al.
NATURE COMMUNICATIONS (2021)
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial
Tiziano Barbui et al.
LANCET HAEMATOLOGY (2021)
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Heinz Gisslinger et al.
LANCET HAEMATOLOGY (2020)
Bystander CD4+T cells: crossroads between innate and adaptive immunity
Hong-Gyun Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Cell-cycle-gated feedback control mediates desensitization to interferon stimulation
Anusorn Mudla et al.
ELIFE (2020)
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
Chunwan Lu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Evelyn Menares et al.
NATURE COMMUNICATIONS (2019)
A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment
Anje Cauwels et al.
ONCOIMMUNOLOGY (2018)
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L. Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Regulation of Murine Natural Killer Cell Development
Wilford Goh et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway
Wei-Ye Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Alessandra Roberto et al.
BLOOD (2015)
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
Nicoletta Cieri et al.
BLOOD (2015)
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
Heinz Gisslinger et al.
BLOOD (2015)
The roles of stem cell memory T cells in hematological malignancies
Ling Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Effector functions of natural killer cell subsets in the control of hematological malignancies
Angela Gismondi et al.
FRONTIERS IN IMMUNOLOGY (2015)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
Mette Ilander et al.
PLOS ONE (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Impairment of CD4+ Cytotoxic T Cells Predicts Poor Survival and High Recurrence Rates in Patients With Hepatocellular Carcinoma
Junliang Fu et al.
HEPATOLOGY (2013)
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia
M. Talpaz et al.
LEUKEMIA (2013)
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Daniel J. Gough et al.
IMMUNITY (2012)
Direct Effects of Type I Interferons on Cells of the Immune System
Sandra Hervas-Stubbs et al.
CLINICAL CANCER RESEARCH (2011)
Interferon-α in acute myeloid leukemia: an old drug revisited
S. Anguille et al.
LEUKEMIA (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
Magdalena Sarasin-Filipowicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
Claus Garbe et al.
MELANOMA RESEARCH (2007)
Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model
Reuben Benjamin et al.
BLOOD (2007)
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Y Zhang et al.
NATURE MEDICINE (2005)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis
D Grebenova et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
In vivo developmental stages in murine natural killer cell maturation
S Kim et al.
NATURE IMMUNOLOGY (2002)
Cancer immunotherapy:: The interferon-α experience
J Kirkwood
SEMINARS IN ONCOLOGY (2002)
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
L Thyrell et al.
ONCOGENE (2002)
Interferon-α treatment in multiple myeloma:: Meta-analysis of 30 randomised trials among 3948 patients
E Fritz et al.
ANNALS OF ONCOLOGY (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
Share Paper
